BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 12075859)

  • 1. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.
    Walter U; Wittstock M; Benecke R; Dressler D
    J Neural Transm (Vienna); 2002 Feb; 109(2):191-6. PubMed ID: 12075859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder.
    Miyamoto M; Miyamoto T; Iwanami M; Muramatsu S; Asari S; Nakano I; Hirata K
    Sleep Med; 2012 Jan; 13(1):102-6. PubMed ID: 22033122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperechogenicity of the substantia nigra in Parkinson's disease.
    Ressner P; Skoloudík D; Hlustík P; Kanovský P
    J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism.
    Tsai CF; Wu RM; Huang YW; Chen LL; Yip PK; Jeng JS
    J Neurol; 2007 Apr; 254(4):501-7. PubMed ID: 17401518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes.
    Walter U; Niehaus L; Probst T; Benecke R; Meyer BU; Dressler D
    Neurology; 2003 Jan; 60(1):74-7. PubMed ID: 12525721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
    Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
    Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease.
    Weise D; Lorenz R; Schliesser M; Schirbel A; Reiners K; Classen J
    Mov Disord; 2009 Aug; 24(11):1669-75. PubMed ID: 19514075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
    Alonso-Canovas A; Tembl Ferrairó JI; Martínez-Torres I; Lopez-Sendon Moreno JL; Parees-Moreno I; Monreal-Laguillo E; Pérez-Torre P; Toledano Delgado R; García Ribas G; Sastre Bataller I; Masjuan J; Martinez-Castrillo JC; Walter U
    Parkinsonism Relat Disord; 2019 Nov; 68():40-45. PubMed ID: 31621617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
    Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
    Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
    Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
    Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantia nigra hyperechogenicity in hypokinetic Huntington's disease patients.
    Lambeck J; Niesen WD; Reinhard M; Weiller C; Dose M; Zucker B
    J Neurol; 2015 Mar; 262(3):711-7. PubMed ID: 25572159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease.
    Huang YW; Jeng JS; Tsai CF; Chen LL; Wu RM
    Mov Disord; 2007 Mar; 22(4):550-5. PubMed ID: 17260344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
    Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
    Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease.
    Lobsien E; Schreiner S; Plotkin M; Kupsch A; Schreiber SJ; Doepp F
    Mov Disord; 2012 Mar; 27(3):450-3. PubMed ID: 22237792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial brain sonography in Parkinson's disease with restless legs syndrome.
    Kwon DY; Seo WK; Yoon HK; Park MH; Koh SB; Park KW
    Mov Disord; 2010 Jul; 25(10):1373-8. PubMed ID: 20544813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transcranial parenchymal sonography in the diagnosis of Parkinson's disease].
    Mijajlović M; Petrović I; Stojković T; Svetel M; Stefanova E; Kostić VS
    Vojnosanit Pregl; 2008 Aug; 65(8):601-5. PubMed ID: 18751340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers.
    Vilas D; Ispierto L; Álvarez R; Pont-Sunyer C; Martí MJ; Valldeoriola F; Compta Y; de Fabregues O; Hernández-Vara J; Puente V; Calopa M; Jaumà S; Campdelacreu J; Aguilar M; Quílez P; Casquero P; Lomeña F; Ríos J; Tolosa E
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1170-6. PubMed ID: 26306001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson's disease: a Chinese population-based study.
    Li T; Shi J; Qin B; Fan D; Liu N; Ni J; Zhang T; Zhou H; Xu X; Wei M; Zhang X; Wang X; Liu J; Wang Y; Tian J
    Neurol Sci; 2020 Mar; 41(3):661-667. PubMed ID: 31754876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcranial sonography in movement disorders.
    Bartova P; Skoloudik D; Bar M; Ressner P; Hlustik P; Herzig R; Kanovsky P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Dec; 152(2):251-8. PubMed ID: 19219216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.